CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-25 | Gilgallon Craig S. EVP and General Counsel | Grant or award · Stock Option (right to Buy) | +30,000 | 30,000 | ||
| 2021-12-10 | Hargroves Thomas Jeffrey Director | Purchase | +8,300 | 8,300 | ||
| 2021-12-10 | Hargroves Thomas Jeffrey Director | Grant or award · Warrant to Purchase Common Stock | +8,300 | 8,300 | ||
| 2021-12-10 | Schaffer Shane J. Chief Executive Officer | Purchase | +16,500 | 16,500 | ||
| 2021-12-10 | Schaffer Shane J. Chief Executive Officer | Grant or award · Warrant to Purchase Common Stock | +16,500 | 16,500 | ||
| 2021-12-10 | GIVENS GREGG WM Director | Purchase | +16,500 | 33,318 | ||
| 2021-12-10 | GIVENS GREGG WM Director | Grant or award · Warrant to Purchase Common Stock | +16,500 | 16,500 | ||
| 2021-12-10 | Werth Peter J. Director | Purchase | +8,300 | 844,731 | ||
| 2021-12-10 | Werth Peter J. Director | Grant or award · Warrant to Purchase Common Stock | +8,300 | 8,300 | ||
| 2021-12-07 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +4,492 | 4,492 | ||
| 2021-12-07 | Callahan Jennifer L. Corporate Controller | Grant or award · Stock Option (right to Buy) | +22,459 | 22,459 | ||
| 2021-12-07 | Medeiros Curtis Director | Grant or award · Stock Option (right to Buy) | +8,983 | 8,983 | ||
| 2021-12-07 | Conroy Jeffrey X Director | Grant or award · Stock Option (right to Buy) | +8,983 | 8,983 | ||
| 2021-12-07 | Hargroves Thomas Jeffrey Director | Grant or award · Stock Option (right | +8,983 | 8,983 | ||
| 2021-12-07 | Myers Laurie EVP and COO | Grant or award · Stock Option (right to Buy) | +67,376 | 67,376 | ||
| 2021-12-07 | Gilgallon Craig S. EVP and General Counsel | Grant or award · Stock Option (right to Buy) | +67,376 | 67,376 | ||
| 2021-12-07 | Gallagher Patrick Joseph Director | Grant or award · Stock Option (right to Buy) | +8,983 | 8,983 | ||
| 2021-12-07 | Schaffer Shane J. Chief Executive Officer | Grant or award · Stock Option (right to Buy) | +179,668 | 179,668 | ||
| 2021-12-07 | GIVENS GREGG WM Director | Grant or award · Stock Option (right to Buy) | +8,983 | 8,983 | ||
| 2021-12-07 | Silva Raul R. EVP and Chief Science Officer | Grant or award · Stock Option (right to Buy) | +4,492 | 4,492 |
Page 10 of 11 · 202 trades